HomeNews

News

FLAURA2 Reveals Tagrisso Plus Chemo Boosts Survival in EGFR+ Lung Most cancers

Dr. Eric Singhi sat down with CURE to interrupt down the newest findings from the section 3 FLAURA2 examine, offered on the World...

FDA Grants Orphan Drug Designation to BA-101 in Glioblastoma

The FDA has granted orphan drug designation to the investigational remedy BA-101 for the remedy of sufferers with glioblastoma.The U.S. Meals and Drug...

Ifinatamab Deruxtecan Reveals Exercise in Beforehand Handled ES-SCLC

Ifinatamab deruxtecan (I-DXd) at 12 mg/kg could provide significant advantages for sufferers with beforehand handled extensive-stage small cell lung most cancers, in keeping...

Tagrisso With Chemotherapy Improves Survival in EGFR+ NSCLC

Individuals with EGFR+ NSCLC whose illness unfold exterior the mind after therapy with Tagrisso lived longer once they saved taking Tagrisso together with...

Iza-bren Plus Tagrisso Might Supply a New Choice for Superior Lung Most cancers

Iza-bren and Tagrisso confirmed useful outcomes as an preliminary remedy for superior/metastatic EGFR-mutated NSCLC: © inventory.adobe.com.A mixture of Iza-bren (izalontamab brengitecan; BL-B01D1) and...

Hot Topics